 Connection
Carolyn Lefkowits to Genital Neoplasms, Female
This is a "connection" page, showing publications Carolyn Lefkowits has written about Genital Neoplasms, Female.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
7.435 |
|
|
|
-
Persenaire C, Spinosa DL, Brubaker LW, Lefkowits CJ. Incorporation of Palliative Care in Gynecologic Oncology. Curr Oncol Rep. 2023 11; 25(11):1295-1305.
Score: 0.821
-
Rauh LA, Sullivan MW, Camacho F, Janke MJ, Duska LR, Chandler C, Sukumvanich P, Courtney-Brooks M, Lefkowits C. Validation of the surprise question in gynecologic oncology: A one-question screen to promote palliative care integration and advance care planning. Gynecol Oncol. 2020 06; 157(3):754-758.
Score: 0.641
-
Ross ME, Wheeler LJ, Flink DM, Lefkowits C. Pre-operative opioid use in gynecologic oncology: a common comorbidity relevant to the peri-operative period. Int J Gynecol Cancer. 2019 11; 29(9):1411-1416.
Score: 0.618
-
Lefkowits C, Bevis K, Carey EC, Sheeder J, Arnold RM, Podgurski L. Gynecologic oncology providers endorse practice-changing impact of communication skills training. Gynecol Oncol. 2019 06; 153(3):633-638.
Score: 0.602
-
Ramzan AA, Fischer S, Buss MK, Urban RR, Patsner B, Duska LR, Fisher CM, Lefkowits C. Opioid use in gynecologic oncology in the age of the opioid epidemic: Part II - Balancing safety & accessibility. Gynecol Oncol. 2018 05; 149(2):401-409.
Score: 0.558
-
Lefkowits C, Buss MK, Ramzan AA, Fischer S, Urban RR, Fisher CM, Duska LR. Opioid use in gynecologic oncology in the age of the opioid epidemic: Part I - Effective opioid use across clinical settings, a society of gynecologic oncology evidence-based review. Gynecol Oncol. 2018 05; 149(2):394-400.
Score: 0.556
-
Lefkowits C, Duska L. Opioid Use in Gynecologic Oncology; Balancing Efficacy, Accessibility and Safety: An SGO Clinical Practice Statement. Gynecol Oncol. 2017 02; 144(2):232-234.
Score: 0.512
-
Lefkowits C, Solomon C. Palliative Care in Obstetrics and Gynecology. Obstet Gynecol. 2016 12; 128(6):1403-1420.
Score: 0.511
-
Lefkowits C, Teuteberg W, Courtney-Brooks M, Sukumvanich P, Ruskin R, Kelley JL. Improvement in symptom burden within one day after palliative care consultation in a cohort of gynecologic oncology inpatients. Gynecol Oncol. 2015 Mar; 136(3):424-8.
Score: 0.447
-
Lefkowits C, Binstock AB, Courtney-Brooks M, Teuteberg WG, Leahy J, Sukumvanich P, Kelley JL. Predictors of palliative care consultation on an inpatient gynecologic oncology service: are we following ASCO recommendations? Gynecol Oncol. 2014 May; 133(2):319-25.
Score: 0.422
-
Lefkowits C, W Rabow M, E Sherman A, K Kiet T, Ruskin R, Chan JK, Chen LM. Predictors of high symptom burden in gynecologic oncology outpatients: who should be referred to outpatient palliative care? Gynecol Oncol. 2014 Mar; 132(3):698-702.
Score: 0.419
-
Salyer C, Littell RD, Pearl ML, Brown AJ, Popowich S, Lefkowits C, Spoozak L. Palliative care in gynecologic oncology: a narrative review of current literature and vision for the future. Ann Palliat Med. 2022 Nov; 11(11):3542-3554.
Score: 0.192
-
Akapo A, Anishchenko K, Lefkowits C, Greenwood AL. Therapeutic Options for Brain Metastases in Gynecologic Cancers. Curr Treat Options Oncol. 2022 11; 23(11):1601-1613.
Score: 0.192
-
Nitecki R, Fu S, Jorgensen KA, Gray L, Lefkowits C, Smith BD, Meyer LA, Melamed A, Giordano SH, Ramirez PT, Rauh-Hain JA. Employment disruption among women with gynecologic cancers. Int J Gynecol Cancer. 2022 01; 32(1):69-78.
Score: 0.180
-
Shalowitz DI, Lefkowits C, Landrum LM, von Gruenigen VE, Spillman MA. Principles of ethics and critical communication during the COVID-19 pandemic. Gynecol Oncol. 2020 09; 158(3):526-530.
Score: 0.164
-
Kim CH, Lefkowits C, Holschneider C, Bixel K, Pothuri B. Managing opioid use in the acute surgical setting: A society of gynecologic oncology clinical practice statement. Gynecol Oncol. 2020 06; 157(3):563-569.
Score: 0.160
-
Garcia C, Lefkowits C, Pelkofski E, Blackhall L, Duska LR. Prospective screening with the validated Opioid Risk Tool demonstrates gynecologic oncology patients are at low risk for opioid misuse. Gynecol Oncol. 2017 11; 147(2):456-459.
Score: 0.134
-
Hay CM, Lefkowits C, Crowley-Matoka M, Bakitas MA, Clark LH, Duska LR, Urban RR, Creasy SL, Schenker Y. Strategies for Introducing Outpatient Specialty Palliative Care in Gynecologic Oncology. J Oncol Pract. 2017 09; 13(9):e712-e720.
Score: 0.134
-
Hay CM, Lefkowits C, Crowley-Matoka M, Bakitas MA, Clark LH, Duska LR, Urban RR, Chen LM, Creasy SL, Schenker Y. Gynecologic Oncologist Views Influencing Referral to Outpatient Specialty Palliative Care. Int J Gynecol Cancer. 2017 03; 27(3):588-596.
Score: 0.130
-
Guntupalli SR, Brennecke A, Behbakht K, Tayebnejad A, Breed CA, Babayan LM, Cheng G, Ramzan AA, Wheeler LJ, Corr BR, Lefkowits C, Sheeder J, Matsuo K, Flink D. Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant Neoplasm: A Randomized Clinical Trial. JAMA Netw Open. 2020 06 01; 3(6):e207410.
Score: 0.041
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|